Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.3, 1999-09, pp. : 285-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Cost of Male Erectile Dysfunction Using a Decision Analytic Model: For a Hypothetical Managed-Care Plan of 100 000 Members

By Tan H.L.

PharmacoEconomics, Vol. 17, Iss. 1, 2000-01 ,pp. : 77-107

Adis International

Access to resources Recommend Favorite

Reflecting on racial disparity in US managed-care

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 368, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The development of an anticoagulation service in a managed-care environment is `feasible'

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Sickle cell disease screening opportunities for managed-care

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

A randomized, naturalistic cost-effectiveness study in a managed health care setting

By Heiligenstein J.H. Simon G.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 256-257

Elsevier

Access to resources Recommend Favorite